Why choose us?
● 100-level GMP biopharmaceutical production workshop, the quality standard can reach 6 Sigma
● All products are produced strictly accordance to CE & FDA standard on Medical Devices.
● OTESALY is registered in 54 countries such as the European Union, the United States, Colombia, Mexico, Brazil, Russia, Kazakhstan and Iraq in the past 19 years. In the same time, our popularity and positive approval rate is still rising rapidly.
● Delivery within 24 hours after receipt of payment.
● After-sales problem response speed does not exceed 48 hours.
● Your branded products catalogs can be designed for free.
● Product operation video can be provided.
● OEM Meso Treatment for Skin
|
Name |
OTESALY® Skin Rejuvenation with 8% HA Solution |
|
Specifications |
5 ml*10 vials/box |
|
Ingredients |
hyaluronic acid(8%), Multi-vitamins, Amino Acids and Mineral. |
|
Recommend treatment |
Once in 2 week |
|
Function
|
Skin hydration, radiance, and anti-aging such as large pores, fine line, and dull skin. |
|
Usage depth |
Dermis of skin |
|
Usage method |
Meso gun, Syringe, Dermapen or meso roller |
|
Shelf life |
2 years |
|
Storage |
Room temperature |
OTESALY® Skin rejuvenating solution with 8% Hyaluronic Acid mesotherapy treatment reduces fine lines and wrinkles by creating new skin cells, strengthens skin elasticity by stimulating the synthesis of collagen, elastin and other ECM, moisturizes dry skin and helps it maintain its optimal moisture balance. This type of mesotherapy is ideal for mature and dry skin types.
Functions:
● Moisturizing properties that help maintain moisture balance
● Strengthens skin elasticity and induces collagen synthesis
● Reduces fine lines and wrinkles by regenerating new skin cells
● Leaves skin fresh and renewed
● Ideal for mature and dry skin types
● Improve the appearance of the skin: acne, acne, scars, stretch marks, pore reduction
Tips:
You can mix the OTESALY® PDRN with 3ml OTESALY® Skin rejuvenation solution with 8%HA for more obvious results. We add PDRN ingredients and 10ppm of each biomimetic peptide per vial on the basis of the original mesotherapy products to achieve the effect of 1+1>2.
